Holen Sie sich die Stockscreener-App
2.80
0.40%
-0.02
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ACHV?
Forum
Prognose
Aktiensplit
Achieve Life Sciences Inc Aktie (ACHV) Neueste Nachrichten
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2025 Earnings Call Transcript - Insider Monkey
Achieve Life Sciences Announces Publication in Nicotine & - GlobeNewswire
Q1 Earnings Estimate for ACHV Issued By HC Wainwright - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Achieve Life Sciences (NASDAQ:ACHV) - MarketBeat
H.C. Wainwright reiterates Buy on Achieve Life Sciences stock By Investing.com - Investing.com Canada
Achieve Life Sciences (ACHV): HC Wainwright & Co. Reiterates Buy Rating | ACHV Stock News - GuruFocus
Earnings Call Summary | Achieve Life(ACHV.US) Q4 2025 Earnings Conference - 富途牛牛
Achieve Life Sciences outlines first half 2027 cytisinicline launch supported by US manufacturing shift and AI-driven commercialization - MSN
Achieve Life Sciences stock falls as commercial launch pushed to 2027 - Investing.com Canada
Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Challenges - GuruFocus
Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Achieve Life Sciences Reports 2025 Financial Results, Advances Cytisinicline NDA for Smoking and Vaping Cessation, Announces U.S. Manufacturing Partnership with Adare Pharma Solutions 12 - Minichart
Achieve Life Sciences Sees Unusually Large Options Volume (NASDAQ:ACHV) - MarketBeat
Achieve Life Sciences Q4 Earnings Call Highlights - MarketBeat
Achieve Life Sciences, Inc. 2025 10-K Annual Report: Business Overview, Risk Factors, and Financial Highlights - Minichart
ACHV: Cytisinicline NDA accepted; U.S. launch planned for 1H 2027 with robust supply and payer strategy - TradingView
Achieve Life Sciences reports fourth-quarter results in line with expectations - MSN
ACHV: NDA review progresses for cytisinicline, with U.S. launch targeted for 1H 2027 amid strong clinical data - TradingView
Earnings call transcript: Achieve Life Sciences Q4 2025 reports stable EPS, stock dips - Investing.com
Achieve (ACHV) Advances Cytisinicline for Smoking Cessation Solu - GuruFocus
Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% - AlphaStreet
Achieve Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected - AlphaStreet
Achieve Life Sciences meets fourth quarter estimates By Investing.com - Investing.com Australia
Achieve Life Sciences (NASDAQ:ACHV) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Achieve Life Sciences meets fourth quarter estimates - Investing.com
ACHIEVE LIFE SCIENCES ($ACHV) Releases Q4 2025 Earnings - Quiver Quantitative
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - The Manila Times
Achieve Life Sciences 2025 10-K: Net loss $54.6M, EPS $(1.25) - TradingView
Earnings Scheduled For March 24, 2026 - Benzinga
Cytisinicline outlook at Achieve Life Sciences (NASDAQ: ACHV) amid FDA review and cash risk - Stock Titan
Achieve Life Sciences (NASDAQ: ACHV) deepens 2025 loss while eyeing 2026 FDA decision - Stock Titan
Achieve taps U.S. manufacturer for quit-smoking pill ahead of FDA date - Stock Titan
Achieve Life Sciences (ACHV) Q4 Earnings Preview: What to Expect - GuruFocus
Achieve Life Sciences Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 - The Manila Times
Nicotine-dependence drug developer schedules March 24 update on 2025 results - Stock Titan
Activity Recap: How does Achieve Life Sciences Inc score in quality rankingsPrice Action & AI Driven Stock Reports - baoquankhu1.vn
Achieve Life Sciences, Inc. $ACHV Shares Sold by Clearline Capital LP - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving Average – Time to Sell? - Defense World
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200 Day Moving AverageTime to Sell? - MarketBeat
ACHV PE Ratio & Valuation, Is ACHV Overvalued - Intellectia AI
Achieve Life Sciences, Inc. advances novel smoking cessation treatment at SRNT2026 - Traders Union
How Achieve Life Sciences Inc. stock reacts to global recession fearsQuarterly Market Review & AI Enhanced Trading Signals - Naître et grandir
Aug Breakouts: Is Achieve Life Sciences Inc stock influenced by commodity pricesWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Achieve Life Sciences outlines Late-breaking survey results on ORCA-OL unveiled - Traders Union
Achieve Life Sciences, Inc. $ACHV Shares Sold by Propel Bio Management LLC - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Achieve Life Sciences presents cytisinicline quit-smoking data - Investing.com
Achieve Life Sciences presents cytisinicline quit-smoking data By Investing.com - Investing.com UK
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study - marketscreener.com
New study: smokers who failed other quit drugs stop with cytisinicline - Stock Titan
ACHV Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Achieve Life Sciences (ACHV) Expected to Announce Earnings on Tuesday - MarketBeat
Caris Life Sciences Completes Interim Readout of Achieve 1 Study - Finviz
/C O R R E C T I O N -- Caris Life Sciences/ - PR Newswire
Achieve Life Sciences, Inc. advances new smoking cessation treatment as over 16 million Americans face heart disease - Traders Union
Achieve Life Sciences (NASDAQ:ACHV) Shares Pass Above 200 Day Moving AverageWhat's Next? - MarketBeat
ACHV SEC FilingsAchieve Life Sciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What is Achieve Life Sciences Inc.’s book value per sharePortfolio Value Report & Real-Time Stock Entry Alerts - mfd.ru
Aug Reactions: Whats the MACD signal for Achieve Life Sciences Inc2025 Macro Impact & Smart Money Movement Alerts - baoquankhu1.vn
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering - MSN
Is Achieve Life Sciences Inc. stock trending bullishWeekly Loss Report & Fast Momentum Entry Tips - mfd.ru
Achieve Life Sciences appoints Oki as Chief Financial Officer - Intellectia AI
What are Achieve Life Sciences Inc.’s recent SEC filings showingGlobal Markets & Precise Buy Zone Identification - mfd.ru
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):